
2seventy bio, Inc.
USD5.00
+0.00 (+0.00%)
CEO
William D. Baird III,
IPO Date
2021-11-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.00
Prev. Close
$5.00
Day Low
$5.00
Day High
$5.00
52W Low
$2.29
52W High
$5.30
Market Cap
$0.27B
Volume
1.16M
| 27 Jun 2024 |
| Wedbush |
| Neutral |
| Neutral |
| maintain |
| 9 May 2024 | Canaccord Genuity | Buy | Buy | maintain |
| 8 Apr 2024 | Citigroup | Buy | Buy | maintain |
| 18 Mar 2024 | Wedbush | Neutral | Neutral | maintain |
| 31 Jan 2024 | TD Cowen | Outperform | Market Perform | downgrade |
| 31 Jan 2024 | Leerink Partners | Market Perform | Outperform | upgrade |
| 20 Nov 2023 | Wedbush | Outperform | Neutral | downgrade |